StockNews.com started coverage on shares of NantHealth (NASDAQ:NH – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the stock.
NantHealth Price Performance
NH opened at $0.34 on Tuesday. NantHealth has a twelve month low of $1.24 and a twelve month high of $9.75. The company has a fifty day moving average of $0.39 and a 200-day moving average of $0.39. The stock has a market cap of $2.63 million, a PE ratio of -0.04 and a beta of 1.82.
Institutional Investors Weigh In On NantHealth
Large investors have recently bought and sold shares of the stock. Atria Wealth Solutions Inc. grew its holdings in NantHealth by 117.7% in the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock worth $205,000 after purchasing an additional 265,949 shares during the period. Millennium Management LLC acquired a new stake in NantHealth in the second quarter worth $110,000. Goldman Sachs Group Inc. bought a new position in shares of NantHealth in the second quarter valued at $36,000. Finally, Susquehanna International Group LLP bought a new position in shares of NantHealth in the first quarter valued at $25,000. 4.50% of the stock is currently owned by institutional investors and hedge funds.
NantHealth Company Profile
NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.
See Also
- Five stocks we like better than NantHealth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Comprehensive PepsiCo Stock Analysis
- What is a Stock Market Index and How Do You Use Them?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is the Nikkei 225 index?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.